Your account is not claimed yet. You can sign up with ORCID to claim your account.

Ayse Elif Erson-Bensan (Ayse E Erson-Bensan, Ayse Elif Erson Bensan)

Scopus Author ID Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 11

Top Venues

eLife

The FEBS journal

Cancer immunology, immunotherapy : CII

Oncogene

Orta Dogu Teknik Universitesi

University of Michigan (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Orta Dogu Teknik Universitesi Sep 1o 2018

Turkey

Prof :: Biological Sciences

Education History

University of Michigan

United States

PHD :: Human genetics

Publications

Roberta Cacioppo, Hesna Begum Akman, Taner Tuncer, Ayse Elif Erson-Bensan, Catherine Lindon
Differential translation of mRNA isoforms underlies oncogenic activation of cell cycle kinase Aurora A. eLife 12 (2023)
Murat Erdem, Mustafa Cicek, Ayse Elif Erson-Bensan
Versatile RNA: overlooked gems of the transcriptome. The FEBS journal (2023)
Roberta Cacioppo, Hesna Begum Akman, Taner Tuncer, Ayse Elif Erson-Bensan, Catherine Lindon
Differential translation of mRNA isoforms underlies oncogenic activation of cell cycle kinase Aurora A. eLife 12 (2023)
Murat Erdem, Mustafa Cicek, Ayse Elif Erson-Bensan
Versatile RNA: Overlooked gems of the transcriptome. The FEBS journal (2023)
Didem Naz Dioken, Ibrahim Ozgul, Irem Yilmazbilek, Mustafa Cengiz Yakicier, Ezgi Karaca, Ayse Elif Erson-Bensan
An alternatively spliced PD-L1 isoform PD-L1∆3, and PD-L2 expression in breast cancers: implications for eligibility scoring and immunotherapy response. Cancer immunology, immunotherapy : CII (2023)
Roberta Cacioppo, Hesna Begum Akman, Taner Tuncer, Ayse Elif Erson-Bensan, Catherine Lindon
Differential translation of mRNA isoforms underlies oncogenic activation of cell cycle kinase Aurora A. eLife 12 (2023)
Riccardo Di Fiore, Sherif Suleiman, Francesca Pentimalli, Sharon A O'Toole, John J O'Leary, Mark P Ward, Neil T Conlon, Maja Sabol, Petar Ozretić, Ayse Elif Erson-Bensan, Nicholas Reed, Antonio Giordano, C. Simon Herrington, Jean Calleja-Agius
Could MicroRNAs Be Useful Tools to Improve the Diagnosis and Treatment of Rare Gynecological Cancers? A Brief Overview. International journal of molecular sciences 22 (8) (2021)
Ayse Elif Erson-Bensan
RNA-biology ruling cancer progression? Focus on 3'UTRs and splicing. Cancer metastasis reviews 39 (3) (2021)
Ayca Circir, Gozde Koksal Bicakci, Busra Savas, Didem Naz Doken, Şevki Onur Henden, Tolga Can, Ezgi Karaca, Ayse Elif Erson-Bensan
A C-term truncated EIF2Bγ protein encoded by an intronically polyadenylated isoform introduces unfavorable EIF2Bγ-EIF2γ interactions. Proteins (2021)
Esra Cicek, Ayca Circir, Merve Oyken, Ozge Akbulut, Didem Naz Dioken, Sezen Guntekin Ergun, Rengul Cetin-Atalay, Aysegul Sapmaz, Huib Ovaa, Özgür Sahin, Ayse Elif Erson-Bensan
EGF-SNX3-EGFR axis drives tumor progression and metastasis in triple-negative breast cancers. Oncogene (2021)
Aysegul Sapmaz, Ilana Berlin, Erik Bos, Ruud H Wijdeven, Hans Janssen, Rebecca Konietzny, Jimmy J Akkermans, Ayse Elif Erson-Bensan, Roman I Koning, Benedikt Mathias Kessler, Jacques Neefjes, Huib Ovaa
USP32 regulates late endosomal transport and recycling through deubiquitylation of Rab7. Nature communications 10 (1) (2019)

Ayse Elif Erson-Bensan.css-eqlu8i{font-size:small;padding-left:4px;} (Ayse E Erson-Bensan, Ayse Elif Erson Bensan)

Publication Activity (10 Years)

Top Topics

Top Venues

Ayse Elif Erson-Bensan (Ayse E Erson-Bensan, Ayse Elif Erson Bensan)